Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry

Niels P. G. Hoedemaker, Peter Damman, Jan Paul Ottervanger, Jan Henk E. Dambrink, A. T. Marcel Gosselink, Elvin Kedhi, Evelien Kolkman, Robbert J. de Winter, Arnoud W. J. van't Hof

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)127-138
Number of pages12
JournalEuropean Heart Journal-Cardiovascular Pharmacotherapy
Volume5
Issue number3
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Proton-pump inhibitors
  • Acute coronary syndrome
  • Dual antiplatelet therapy
  • Registry
  • Outcomes
  • ACUTE MYOCARDIAL-INFARCTION
  • ST-SEGMENT ELEVATION
  • DUAL-ANTIPLATELET THERAPY
  • BASE-LINE CHARACTERISTICS
  • PLATELET INHIBITION
  • CLINICAL-OUTCOMES
  • CONCOMITANT USE
  • EUROPEAN-SOCIETY
  • TASK-FORCE
  • 2017 ESC

Cite this